ScienceDaily (Jan. 25, 2012) — Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. Read more.
Toronto’s medical community is buzzing about an invention that could change the way health professionals screen for infectious disease and cancer. “We’ve been working on this, really, for about a decade,” said Dr. Shana Kelley, a scientist at the University of Toronto. Kelley spoke as she held a small black device her hand, shaped like a smartphone but bulkier, with a microchip inside that Kelley says can determine in 15 minutes if you have cancer or an infectious disease. Read more.